Medicare Enrolled
Dr. George Kariampuzha, MD
Neurology · Tyler, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kariampuzha from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kariampuzha?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kariampuzha
Dr. George Kariampuzha is a neurology specialist in Tyler, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kariampuzha performed 1,792 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kariampuzha received a total of $39,125 from 37 pharmaceutical and/or device companies across 160 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kariampuzha is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 20% volume in TX
$39,125 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,792
Medicare services
Top 20% in TX for neurology
Not available
Unique patients (not deduplicated)
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
340 | $104 | $406 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
318 | $35 | $228 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
193 | $68 | $289 |
| Continuous intraoperative neurophysiology monitoring, remote Remote monitoring of nerve and brain function during surgery, billed in 15-minute increments. |
162 | $25 | $72 |
| New patient office visit, complex (60-74 min) | 120 | $136 | $496 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
104 | $108 | $458 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
99 | $47 | $204 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
81 | $142 | $664 |
| VEEG monitoring, 12-26 hours with review This procedure involves monitoring brain wave activity along with video recording for 12 to 26 hours. A healthcare professional reviews the data and provides a report. |
72 | $152 | $470 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
43 | $38 | $86 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
32 | $23 | $210 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
31 | $165 | $624 |
| Electromyography of 2 extremities A test that measures the electrical activity in the muscles of two arms or legs. It helps evaluate nerve and muscle function. |
29 | $63 | $569 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
25 | $125 | $441 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
23 | $41 | $863 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs This procedure involves placing skin electrodes and measuring stimulated sites on the arms and legs. |
22 | $35 | $820 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
20 | $64 | $251 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
17 | $47 | $329 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
17 | $101 | $492 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
16 | $62 | $159 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
16 | $63 | $160 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
12 | $93 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$39,125
Total received (2018-2024)
Avg $5,589/year across 7 years
Top 11% in TX for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
160
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,070
2023
$6,734
2022
$6,542
2021
$9,026
2020
$8,465
2019
$1,511
2018
$776
Payments by company (2024)
ABBVIE INC.
$5,415
Neurocrine Biosciences, Inc.
$122
Takeda Pharmaceuticals U.S.A., Inc.
$117
MDD US Operations, LLC
$116
Amgen Inc.
$107
Biogen, Inc.
$94
UCB, Inc.
$86
PFIZER INC.
$14
Top 3 companies account for 93.1% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$17,683
Allergan, Inc.
$10,086
AbbVie Inc.
$6,786
Amgen Inc.
$749
Neurocrine Biosciences, Inc.
$733
Biogen, Inc.
$345
UCB, Inc.
$314
Biohaven Pharmaceuticals, Inc.
$245
Teva Pharmaceuticals USA, Inc.
$242
Genentech USA, Inc.
$175
Lilly USA, LLC
$169
Lundbeck LLC
$156
Avanir Pharmaceuticals, Inc.
$136
SK Life Science, Inc.
$125
Takeda Pharmaceuticals U.S.A., Inc.
$117
MDD US Operations, LLC
$116
Otsuka Pharmaceutical Development & Commercialization, Inc.
$112
JAZZ PHARMACEUTICALS INC.
$109
Allergan Inc.
$105
ACADIA Pharmaceuticals Inc
$104
HARMONY BIOSCIENCES LLC
$100
Boehringer Ingelheim Pharmaceuticals, Inc.
$83
LivaNova USA, Inc.
$42
EMD Serono, Inc.
$33
Supernus Pharmaceuticals, Inc.
$31
Pharming Healthcare, Inc.
$26
Novartis Pharmaceuticals Corporation
$25
AbbVie, Inc.
$24
GENZYME CORPORATION
$21
Greenwich Biosciences, Inc.
$19
CSL Behring
$19
Kedrion Biopharma Inc.
$17
Alexion Pharmaceuticals, Inc.
$17
US WorldMeds, LLC
$16
Bayer HealthCare Pharmaceuticals Inc.
$16
PFIZER INC.
$14
BOSTON SCIENTIFIC CORPORATION
$14
Top 3 companies account for 88.3% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AJOVY · APOKYN · AUBAGIO · AUSTEDO · Actemra · Aimovig · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · Duopa · EMGALITY · Epidiolex · GENERAL DBS · Gammaked · Gocovri · HYQVIA · Hizentra · INGREZZA · JARDIANCE · MAYZENT · Mavenclad · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · QULIPTA · Repatha · SOLIRIS · SUNOSI · TECFIDERA · TROKENDI XR · TYSABRI · Tysabri · UBRELVY · UPLIZNA · VNS Therapy · Wakix · XCOPRI · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
24
County median income
$71,923
Nearest hospital to ZIP centroid (approximate)
UT HEALTH EAST TEXAS TYLER REGIONAL HOSPITAL
3.0 mi
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kariampuzha is a clinical cardiology specialist, with above-average Medicare volume (top 20% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kariampuzha experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Kariampuzha performed 340 office visit, established patient, complex (40-54 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kariampuzha receive payments from pharmaceutical companies?
Yes. Dr. Kariampuzha received a total of $39,125 from 37 companies across 160 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kariampuzha's costs compare to other neurologists in Tyler?
Dr. Kariampuzha's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kariampuzha) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Tyler
Browse neurologists in Tyler ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in TX
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in TX
Which TX neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology